Incidence Relative risk Hazard ratio  
Bleeding 2.2-3.0% 1.91-2.48   [17-19, 28]
Arterial thromboembolic events 1.0-2.3%   1.82-2.0 [17-19, 22,26,27]
Proteinuria  1.0%     [19]
Gastrointestinal perforation 0.9-2.0%     [17-19]
Wound healing complications 1.0-3.5%     [17-19, 29]
Hypertension 5.3-23.6% 2.98-5.28   [17-19, 23, 25]
Table 1: Bevacizumab induced side effects (grade 3-5).